Penn Medicine Provider
Hematology
Colin James Thomas, MD
5.0
(154)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Temple University School of Medicine
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
5.0

154 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
very knowledgeable and personable.
March 2025
5.0
5.0
dr thomas is an excellent listener and very compassionate
March 2025
5.0
5.0
no problem
March 2025
5.0
5.0
amazing

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Thomas is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Pallawi Torka, Natalie S. Grover, Timothy J. Voorhees, Reem Karmali, Kaitlin Annunzio, Marcus P. Watkins, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study , Hematological Oncology : 2025


Omar Elghawy, Jonathan H Sussman, Austin G Yang, Colin J Thomas, Jordan S Carter, Daniel J Landsburg, Jakub Svoboda, Ellen Kim, Alain H Rook, Jina Chung, John P Plastaras, Michael LaRiviere, Harper Hubbeling, Monica Chelius, Sunita D Nasta, Elise A Chong, Stephen J Schuster, Stefan K Barta Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome , JAMA Dermatology : 2025


Colin J. Thomas, David Porter, Vivianna M. Van Deerlin, Siddharth Bhattacharyya, Veronica Carvajal, Joseph Kim, Salvatore Priore, Guang Yang, James N. Gerson & Stefan K. Barta Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia , Leukemia & Lymphoma : 2025


Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta1, Elise A. Chong1, Stephen J. Schuster1, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta Clinical Impact of Next-Generation Sequencing of T-cell Lymphomas: A Single Institution Experience , Clinical Lymphoma, Myeloma and Leukemia: 2025


Omar Elghawy, Austin G. Yang, Jonathan H. Sussman, Colin J. Thomas, Jordan S. Carter, Daniel J. Landsburg, Jakub Svoboda, Ellen Kim, Alain H. Rook, Jina Chung, Jennifer Villasenor-Park, John P. Plastaras, Michael LaRiviere, Harper Hubbeling, Monica Chelius, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Stefan K. Barta Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome , JAAD: 2024


Omar Elghawy, Miao Cao, Jason Xu, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter, Montreh Tavakkoli, Marco Ruella and Stefan K. Barta Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas , Cancers, 16(19): 2024


Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N. Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study , Blood Cancer J, 14: 2024,182


Colin Thomas, Veronica Carvajal and Stefan Barta Targeted Therapies in the Treatment of Mantle Cell Lymphoma , Cancers, 16(10): 2024,1937


Epperla N, Zhao Q, Moyo T, Watkins MP, Tavakkoli M, Bello C, Torka P, Reddy N, Thomas C, Annunzio K, Christian B, Barta SK, Shouse G, Olszewski AJ, Bartlett NL. Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in USA: A Real World Analysis , Blood Adv: 2023


Rosenberg M, Poluch M, Thomas C, Sindaco P, Khoo A, Porcu P. Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities , Front Oncol, 13: 2023,1275800